NR AIRK
AU Murphy,M.F.
TI Potential clinical benefits and cost savings of universal leucocyte-depletion of blood components
QU Transfusion Science 1998 Dec; 19(4): 343-6
PT journal article
MH Blood Component Transfusion/economics/instrumentation/methods/*standards; Blood Transfusion/adverse effects; Cell Separation/*economics; Comparative Study; Cost-Benefit Analysis; Creutzfeldt-Jakob Syndrome/economics/*prevention & control; Government Agencies; Great Britain; Guidelines; Hematologic Diseases/economics/therapy; Human; Intraoperative Care/economics; Length of Stay; *Leukocytes/chemistry; Postoperative Care/economics; Postoperative Complications/economics/prevention & control; Safety; Surgical Procedures, Operative
AD National Blood Service, John Radcliffe Hospital, Oxford, UK
SP englisch
PO England